t2cure

    OverviewSuggest Edit

    t2cure is a biopharmaceutical company that develops progenitor cell-based regenerative therapeutics. It uses bone marrow-derived cells (BMCs) to provide treatment options to patients suffering from cardiovascular and peripheral arterial diseases, including myocardial infarction and thromboangiitis obliterans.
    TypePrivate
    Founded2006
    HQFrankfurt am Main, DE
    Websitet2cure.de

    Locations

    t2cure is headquartered in
    Frankfurt am Main, Germany

    Location Map

    Latest Updates

    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    t2cure Office Locations

    t2cure has an office in Frankfurt am Main
    Frankfurt am Main, DE (HQ)
    Kennedyallee 93
    Show all (1)

    t2cure Financials and Metrics

    Summary Metrics

    Founding Date

    2006

    t2cure Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    93/100

    SecurityScorecard logo

    t2cure Online and Social Media Presence

    Embed Graph

    t2cure Frequently Asked Questions

    • When was t2cure founded?

      t2cure was founded in 2006.

    • Who are t2cure competitors?

      Competitors of t2cure include Sarepta Therapeutics, Ultragenyx Pharmaceutical and Ionis Pharmaceuticals.

    • Where is t2cure headquarters?

      t2cure headquarters is located at Kennedyallee 93, Frankfurt am Main.

    • Where are t2cure offices?

      t2cure has an office in Frankfurt am Main.

    • How many offices does t2cure have?

      t2cure has 1 office.